Alimta-Cisplatin approval by FDA
Friday, June 29th, 2007The Food and Drugs Administration (FDA) have approved a combination of Alimta and Cisplatin for mesothelioma treatments, and other asbestos-associated diseases. (more…)
The Food and Drugs Administration (FDA) have approved a combination of Alimta and Cisplatin for mesothelioma treatments, and other asbestos-associated diseases. (more…)
Whether mesothelioma patients decide on aggressive treatment of mesothelioma, or decide on only palliative treatment, nutrition plays a vital role (more…)
Non-invasive tests which are usually carried out to help in the mesothelioma diagnosis and staging of malignant mesothelioma are as follows: (more…)
In January 2007, the food and drug administration (FDA) endorsed the mesomark test to assist in observing response to mesothelioma treatments in epithelial and bi-phasic malignant mesothelioma (more…)
There are some new malignant mesothelioma treatments options that are presently undergoing tests. These malignant mesothelioma treatments options usually (more…)